-
Mashup Score: 8Sequencing benchmarked - Nature Biotechnology - 3 year(s) ago
The Sequencing Quality Control 2 (SEQC2/MAQC-IV) project provides resources to aid sequencing reproducibility and highlights factors that can guide platform and software choice.
Source: Nature BiotechnologyCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 6The MAQC Society Announces Publication of Next-Gen Sequencing Best Practice Articles in Nature Biotechnology - 3 year(s) ago
/PRNewswire/ — The Massive Analysis and Quality Control (MAQC) Society, an organization seeking to promote and advance reproducible science principles and…
Source: www.prnewswire.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 2Establishing community reference samples, data... - 3 year(s) ago
The lack of samples for generating standardized DNA datasets for setting up a sequencing pipeline or benchmarking the performance of different algorithms limits the implementation and uptake of cancer genomics. Here, we describe reference call sets obtained from paired tumor–normal genomic DNA (gDNA) samples derived from a breast cancer cell line—which is highly heterogeneous, with an aneuploid…
Source: www.nature.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 21Volume 39 Issue 9, September 2021 - 3 year(s) ago
Volume 39 Issue 9, September 2021
Source: www.nature.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 9Sequencing benchmarked - Nature Biotechnology - 3 year(s) ago
The Sequencing Quality Control 2 (SEQC2/MAQC-IV) project provides resources to aid sequencing reproducibility and highlights factors that can guide platform and software choice.
Source: Nature BiotechnologyCategories: Future of Medicine, Latest HeadlinesTweet
Although the most likely near-term benefit of #SEQC2 will be to encourage best practices when setting up sequencing pipelines, the legacy of its parent group may be to serve as a template for other efforts seeking to benchmark rapidly evolving technologies https://t.co/BSdZzjPNOM https://t.co/54IBR1pGmf